Progress 07/01/23 to 06/30/24
Outputs Target Audience:Sturgeon caviar growers in the United States who are interested in determining early sex identification of their stocks. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?
Nothing Reported
How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?Next Steps As observed in the previous assays, thrombin can be efficiently detected using the mAb immobilized MB and HRP-TMB based signal amplification system. The method can be further optimized and translated to detect Inhibin using the most effective detection mAb identified during the validation tests using lateral flow assays. This approach has the potential to be developed into a rapid field test using a portable absorbance reader.
Impacts What was accomplished under these goals?
In aquaculture enterprises, a non-lethal method for determining the gender of young sturgeon (e.g., three years or younger) would be highly beneficial. Inhibin, an atypical member of the TGF-β superfamily, is reported to be distinguishable in fish gender determination where the maturing male sturgeon exhibit lower level of inhibin, while female sturgeon shows higher concentration. Inhibin is constituted by dimeric units consisting of an alpha subunit and either a beta A or beta B subunit, giving rise to inhibin A and inhibin B, respectively. The intended method for rapid sturgeon fish sexual characteristics determination involves collecting blood from fish, optionally separating serum, measuring the concentration of Inhibin A or Inhibin B using a hand-held device. The device comprises a target-specific capture antibody on a solid-phase and a rapid-developing reporter antibody that can provide colorimetric or other indication of inhibin concentration within 15 minutes. Mote Marine Laboratory has developed three monoclonal antibodies (mAbs) targeting the Inhibin alpha subunit and three mAbs for the beta A subunit. This brief report presents findings from lateral flow assay, a representative rapid test method verifying and comparing inhibin detection efficiency of the mAbs, as well as bead-based assay development strategies, thus laying the groundwork for a rapid sandwich assay or other antibody-based inhibin detection methods. Testing detection antibody efficiency Assay format: Lateral flow immunoassay (LFA) Target: Inhibin A (InhA) Detection probe: Gold nanoparticle (AuNP) conjugated mAbs Mote InhA mAbs - Anti-alpha subunit: 131-0050 (G11); 131-0048 (G6); 131-0047 (H3) Anti-beta A subunit: 131-0051 (H11); 131-0046 (H4); 131-0045 (H7) Sandwich LFA with different mAb pair combinations: Detection H7-AuNP showed high cross-reactivity/ non-specific binding (NSB) paired with capture anti-alpha subunit mAbs. Similarly, detection H4-AuNP paired with capture G6 and G11 showed weak signal and NSB, respectively. Furthermore, BSA blocking on capture test spot and PEG blocking on mAb-AuNP did not resolve the NSB. On the other hand, detection H4-AuNP paired with capture H3 showed better detection signal-noise ratio. Note: All three anti-alpha subunit mAbs-AuNP and H11-AuNP were not achieved due to aggregation. Mote mAbs paired with Ansh mAbs (commercially purchased) showed a high level of NSB or an absence of detection signals. However, using the Ansh mAb pair alone for detection efficiently identified InhA and detected InhA positive serum samples with a good signal-to-noise ratio. When comparing the Mote and Ansh mAb pairs for detecting InhA in different species of sturgeon serum samples, the Ansh mAb pair, unlike the Mote mAbs, demonstrated better detection, corresponding to the known InhA concentrations. Sandwich LFA using different Commercial mAbs: Since functional Mote mAb pairs could not be obtained according to the findings from sandwich LFA, the assay proceeded using the following mAbs from different sources: Anti-alpha subunit: CloudClone 21 (C21); CloudClone 22 (C22); LSBio alpha (LSa) Anti-beta A subunit: Abbexa (Abx); LSBio betaA (LSb) Among the tested commercial mAb combinations, the sandwich LFA using anti-alpha mAb C21 and anti-beta A mAb Abx-AuNP demonstrated efficient cross-species serum InhA detection. It exhibited a concentration-dependent response in Russian sturgeon serum samples with a favorable signal-to-noise ratio. However, other combinations resulted in high NSB or the absence of any signal. While the C21 and Abx mAb pair showed positive detection, the signal intensity was not as robust as observed with the Ansh mAb pair. Competitive LFA detection of rInhA Most anti-alpha and anti-beta A mAb pairs exhibited high NSB or no signal. This can be due to adjacent binding sites availability, poor binding selectivity, or complexity of the matrix, causing high cross-reactivity, or steric hindrance, due to which the sandwich assay can become challenging. Consequently, the assay transitioned to a competitive format using only anti-alpha mAb, capable of detecting all inhibin rather than just inhibin A. Due to the incompatibility of anti-alpha mAbs for AuNP conjugation, an indirect assay principle was adopted using anti-IgG-AuNP. Mote and the commercial anti-alpha mAbs exhibited positive detection of the Inhibin alpha subunit in the indirect LFA without any background noise. In the indirect competitive assay, G6, H3, and C21 mAbs demonstrated InhA detection through signal inhibition in the presence of free 5 ng/mL InhA in the diluent. Further optimization can enhance signal resolution for a more effective detection dynamic range. Bead-based competitive immunoassay for rapid Inhibin detection with glucometer readout Based on mAb binding efficiency observed in the LFA analysis, a magnetic bead-based competitive assay can be developed for a two-step incubation, providing bound-free phase detection of inhibin in serum samples at sturgeon farming sites. The method involves immobilizing an anti-inhibin alpha subunit mAb on magnetic beads (MB), using a reference standard inhibin-invertase conjugate to compete with sample inhibin. The invertase enzymatic reaction generates glucose, which is readable by a glucometer--a measurement correlating to the inhibin present in the original sample. After mixing the sample with the mAb-coated MB, inhibin in the sample binds to the mAb-MB. Following incubation, the removal of the supernatant eliminates the complex matrix. Addition of the reference inhibin-invertase conjugate, which binds to the remaining binding sites on the mAb, is then followed by another incubation. Removing the supernatant for sucrose hydrolysis enzymatic reaction produces glucose that can be read by a glucometer. Higher glucose levels indicate more inhibin-invertase in the supernatant due to more inhibin in the sample, occupying most of the mAb on MB. The key benefits of this method include a competitive two-step incubation, potentially eliminating the need for a wash step, minimizing matrix complexity, and removing the necessity for an antibody pair, reducing the chance of cross-reactivity. Crucial factors for the assay development include immobilizing mAb on MB, MB-mAb target binding, protein-invertase conjugation, invertase sucrose hydrolysis reaction parameters such as time and pH and ensuring compatibility with competitive assay method. Method development To develop the method, thrombin is used as a mock target due to being a well-characterized protein, commonly available and having a similar molecular mass as Inhibin. Initially, thrombin mAb immobilization on magnetic beads (MB) is optimized using direct detection of as low as 5 ng/mL biotinylated thrombin within 15 minutes with an HRP-TMB-based signal amplification system. Reference thrombin-invertase conjugate is generated using thiol-maleimide click chemistry. Thrombin-invertase conjugate is individually validated using commercial thrombin detection lateral flow strips and sucrose hydrolysis reaction with a glucometer readout. However, using the thrombin mAb immobilized MB to detect thrombin-invertase conjugate in a direct assay does not yield positive detection, likely due to invertase (approx. MW: 270 kDa) hindering the thrombin epitope. To address this, the thiol-maleimide crosslinking is modified with a 12-PEG spacer between thrombin and invertase conjugation, which also could not be positively detected by the direct assay. Another approach uses thrombin-specific detection aptamer immobilized on agarose beads in a direct assay for thrombin-invertase conjugate. This assay detects 100 µg/mL thrombin-invertase conjugate after 30 minutes of incubation with 0.25M sucrose at 37°C, yielding a corresponding positive signal on the glucometer. While effective, this method may not be suitable for rapid and sensitive assays.
Publications
|